Navigation Links
Quark Pharmaceuticals to Participate in IBC's Oligonucleotide Therapeutics: From Concept to Implementation Conference
Date:8/3/2009

. For the structure of these products Quark has licenses from Silence Therapeutics and from Alnylam Pharmaceuticals.

QPI-1007, a siRNA that utilizes a proprietary structure developed by Quark, is being evaluated in advanced IND-enabling preclinical studies as a neuroprotective agent for eye diseases. In addition, Quark has a broad pipeline of siRNA drug candidates based on novel structures developed internally. The Company expects to utilize the structures to develop additional RNAi drug candidates.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at www.quarkpharma.com

    Quark Pharmaceuticals, Inc.         The Ruth Group (investors / media)
    Juliana Friedman                    Sara Ephraim / Janine McCargo
    +972 89 30 5111                     (646) 536-7004 / 7033
    jfriedman@quarkpharma.com           sephraim@theruthgroup.com
                                        jmccargo@theruthgroup.com


'/>"/>
SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
2. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
3. Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage
4. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
5. Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi
6. Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
7. MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
8. Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
9. Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
10. Excaliard Pharmaceuticals Appoints Jay Birnbaum, Ph.D. to the Board of Directors.
11. Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Maui'd Forever ... dedicated to being an effective and cost effective way ... They have partnered up with Tom Barefoot’s Tours providing ... on most of Hawaii’s activities. , They have just ... can get the lowest prices on their Hawaii activities. ...
(Date:6/19/2013)... researchers have focused on two proteins that accumulate in ... to the disease: plaques made up of the protein ... But for the first time, an Alzheimer,s researcher has ... at the interaction of the two proteins with each ... patients and in mouse brains with Alzheimer,s disease. The ...
(Date:6/19/2013)... Orlando, FL (PRWEB) June 19, 2013 Fit ... and Andrea Laing recently held a charity boot camp in ... cystic fibrosis. The fitness boot camp franchise hosted ... a.m. to 11 a.m. with 75 boot camp participants and ... June charity boot camp marks the second fundraiser held for ...
(Date:6/19/2013)... 2013 Arem Wellness was developed and ... expert, Dr. Ridha Arem, who is determined to help ... this goal, Arem Wellness provides a monthly newsletter, a ... program as well as an exceptional supplement line uniquely ... the crucial role diet and nutrition have not only ...
(Date:6/19/2013)... Antonio, TX (PRWEB) June 19, 2013 ... insurers nationwide, today announced the launch of its new ... designed to motivate and inspire participants to reach their ... Walkingspree platform , Walkingspree clients are given more ... needs and member profile. , Corporate clients may choose ...
Breaking Medicine News(10 mins):Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:New Alzheimer's research suggests possible cause: The interaction of proteins in the brain 2Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2Health News:Arem Wellness Announces a Recipe Contest 2Health News:Arem Wellness Announces a Recipe Contest 3Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2
... for ORBIS Children,s Eye Care Project ... ... Pendyala, ages 8 and 6,will launch a kid-inspired and kid-driven campaign on ... goal is to raise $260,000 for a specialized pediatric eye care,unit and ...
... Congress to the economic hardship definition in the ... will deter physicians from pursuing careers in primary ... C. Dale, MD, FACP, president of the American ... committee leaders involved in the legislation. ACP ...
... Oct. 9 MGT Capital Investments,Inc. (Amex: ... on the Healthcare Information,Technology ("HCIT") sector, announced ... Medicexchange PLC, a global web portal that,delivers ... treatment and,surgery planning solutions across breast imaging, ...
... associated with 20 percent of all lung malignancies, scientists say ... that appear to work together are associated with 20 percent ... fetal lung development, researchers report. , Understanding how these genes ... forming, according to the report in this week,s issue of ...
... SAN DIEGO, Oct. 9 Many Americans are obsessed ... obsessed about being,mentally fit. More Americans are becoming aware ... society where knowledge, intelligence, and quick,wits are rewarded. Being ... to effectively train your brain have been lacking,until recently. ...
... Partners announced today that,it has initiated coverage on ... team was pivotal in getting two drugs,approved and ... biotech company and we believe they will do ... Research at Vista Partners. Vista Partners,provides independent, equity ...
Cached Medicine News:Health News:Elementary School Students to Launch 'Kids for Sight' Campaign, to Inspire Other Kids to Pay it Forward 2Health News:Elementary School Students to Launch 'Kids for Sight' Campaign, to Inspire Other Kids to Pay it Forward 3Health News:Revisions to 'College Cost Reduction and Access Act' will create barriers to primary care 2Health News:MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC 2Health News:MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC 3Health News:3 New Lung Cancer Genes Identified 2Health News:Online Game from BrainGrade Can Raise Brain I.Q. 2Health News:Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp. 2
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
(Date:6/19/2013)... 2013 Specialty Coating Systems ... von SCS microRESIST™, einer antimikrobiellen Parylene-Technologie, ... mit Parylene gelungen ist. SCS microRESIST ... mit antimikrobiellen Eigenschaften und erlaubt damit ... beschichteten medizinischen Geräten. (Logo: ...
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... how microbes can block nitric,oxide production - a chemical ... fighting bacteria, MEMPHIS, Tenn., Nov. 3 St. ... which,intracellular pathogens can shut down one of the body,s ... that the microbes,block nitric oxide production by subverting the ...
... presented at the 2008 iSBTc Annual Meeting -, ... a.m. ET to discuss,results -, BRANFORD, Conn., Nov. ... preliminary data from an ongoing Phase II,trial of CR011-vcMMAE, ... patients with unresectable Stage III or Stage IV melanoma.,Dr. ...
Cached Medicine Technology:Parasites That Live Inside Cells Use Loophole to Thwart Immune System 2Parasites That Live Inside Cells Use Loophole to Thwart Immune System 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: